IMMUNE-MODULATORY THERAPY

Image

On behalf of the Journal of Immune Disorder and Therapy : Open Access, as Editor-in-Chief, it is my distinct honour and privilege to inform you that, we are privileged to welcome clinical Society to our journal. As Editor-In-Chief it is my great pleasure and honour to welcome you to the Journal of immune disorder and therapy: Open Access.

The Journal of Immune Disorder and Therapy : Open Access aims to disseminate knowledge and promote discussion through the publication of peer-reviewed, high quality research papers on all topics related to Cancer. The open access journal is published by Insight medical publishing that hosts open access peer-reviewed journals as well as organizes more than 17 Years of Life science Communication in International scientific Conferences.

The Journal of Immune Disorders & Therapy act as a bridge between the medical community and the vast population by dispersing scientific advancements in medical and clinical research on immune disorders and therapy.

This is the longest running independent life science events company with a predominantly academic client base. Our multi professional and multi-speciality approach creates a unique experience that cannot be found with a specialist society or commercially.

Warm Regards,

 

Sofia Khan

Journal Coordinator

Journal of Immune Disorder & Therapy

Email: - immunedis@escientificjournals.com

What’s app No- +3225889658